An international team led by researchers at the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health and Fred Hutchinson Cancer Research Center uncovered the
influence of genetic variation on
vaccine effectiveness after applying cutting - edge DNA sequencing technology to almost 5,000 patient blood samples.